Amer N. Kalaaji

520 total citations
32 papers, 336 citations indexed

About

Amer N. Kalaaji is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Amer N. Kalaaji has authored 32 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 13 papers in Dermatology and 10 papers in Rheumatology. Recurrent topics in Amer N. Kalaaji's work include Autoimmune Bullous Skin Diseases (11 papers), Eosinophilic Disorders and Syndromes (5 papers) and Urticaria and Related Conditions (4 papers). Amer N. Kalaaji is often cited by papers focused on Autoimmune Bullous Skin Diseases (11 papers), Eosinophilic Disorders and Syndromes (5 papers) and Urticaria and Related Conditions (4 papers). Amer N. Kalaaji collaborates with scholars based in United States, Switzerland and Australia. Amer N. Kalaaji's co-authors include Julia S. Lehman, Alison J. Bruce, Jacqueline L. Gerhart, Svetomir N. Markovic, Iftikhar Ahmed, Mark R. Pittelkow, Mark D.P. Davis, Ken McCullough, John B. Hay and Faraz Kureshi and has published in prestigious journals such as Clinical Infectious Diseases, Journal of the American Academy of Dermatology and Mayo Clinic Proceedings.

In The Last Decade

Amer N. Kalaaji

29 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amer N. Kalaaji United States 12 143 104 98 90 66 32 336
Neetu Bhari India 10 97 0.7× 61 0.6× 105 1.1× 50 0.6× 45 0.7× 83 334
Bela Shah India 9 76 0.5× 33 0.3× 73 0.7× 96 1.1× 48 0.7× 52 249
Parvaneh Hatami Iran 11 125 0.9× 29 0.3× 168 1.7× 51 0.6× 54 0.8× 58 352
O Mourellou Greece 11 167 1.2× 93 0.9× 106 1.1× 112 1.2× 70 1.1× 18 344
Ibrahim Galadari United Arab Emirates 15 52 0.4× 71 0.7× 312 3.2× 49 0.5× 24 0.4× 32 529
Vincent P. Barranco United States 12 125 0.9× 64 0.6× 152 1.6× 143 1.6× 107 1.6× 25 448
Ayşe Esra Koku Aksu Türkiye 11 53 0.4× 80 0.8× 241 2.5× 41 0.5× 13 0.2× 62 390
Sascha Ständer Germany 10 112 0.8× 26 0.3× 100 1.0× 108 1.2× 83 1.3× 30 260
Yukie Endo Japan 11 76 0.5× 96 0.9× 120 1.2× 162 1.8× 25 0.4× 26 401
Maria Manuel Brites Portugal 9 130 0.9× 122 1.2× 165 1.7× 130 1.4× 57 0.9× 25 373

Countries citing papers authored by Amer N. Kalaaji

Since Specialization
Citations

This map shows the geographic impact of Amer N. Kalaaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer N. Kalaaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer N. Kalaaji more than expected).

Fields of papers citing papers by Amer N. Kalaaji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amer N. Kalaaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer N. Kalaaji. The network helps show where Amer N. Kalaaji may publish in the future.

Co-authorship network of co-authors of Amer N. Kalaaji

This figure shows the co-authorship network connecting the top 25 collaborators of Amer N. Kalaaji. A scholar is included among the top collaborators of Amer N. Kalaaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amer N. Kalaaji. Amer N. Kalaaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehman, Julia S., Nessa Aghazadeh, Michael Camilleri, et al.. (2024). Indirect immunofluorescence (IIF) testing for IgG4 and IgG increases sensitivity over IIF testing for IgG alone in pemphigoid and pemphigus diseases: A retrospective study of 278 cases. Journal of the American Academy of Dermatology. 92(6). 1360–1362.
2.
Lehman, Julia S., Emma F. Johnson, Michael Camilleri, et al.. (2021). Impact of adding an IgG4 conjugate to routine direct immunofluorescence testing for subepithelial and intraepithelial autoimmune blistering disorders. Journal of Cutaneous Pathology. 49(4). 358–362. 4 indexed citations
3.
Shon, Wonwoo, David A. Wada, & Amer N. Kalaaji. (2016). Radiation-induced pemphigus or pemphigoid disease in 3 patients with distinct underlying malignancies.. PubMed. 97(3). 219–22. 14 indexed citations
4.
Kalaaji, Amer N., et al.. (2013). CAM use in dermatology. Is there a potential role for honey, green tea, and vitamin C?. Complementary Therapies in Clinical Practice. 20(1). 11–15. 13 indexed citations
5.
Kalaaji, Amer N., Dietlind L. Wahner‐Roedler, Amit Sood, et al.. (2011). Use of complementary and alternative medicine by patients seen at the dermatology department of a tertiary care center. Complementary Therapies in Clinical Practice. 18(1). 49–53. 24 indexed citations
6.
Lehman, Julia S., Dédée F. Murrell, Michael Camilleri, & Amer N. Kalaaji. (2011). Infection and Infection Prevention in Patients Treated with Immunosuppressive Medications for Autoimmune Bullous Disorders. Dermatologic Clinics. 29(4). 591–598. 17 indexed citations
7.
Kalaaji, Amer N., et al.. (2010). The management of mucous membrane pemphigoid and pemphigus. Dermatologic Therapy. 23(3). 268–280. 40 indexed citations
8.
Kalaaji, Amer N., Jun Lü, Svetomir N. Markovic, Esteban Celis, & Mark R. Pittelkow. (2010). Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model. Cytokine. 49(3). 287–293. 3 indexed citations
9.
Gerhart, Jacqueline L. & Amer N. Kalaaji. (2009). Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications. Journal of the American Academy of Dermatology. 62(6). 957–961. 21 indexed citations
10.
Davis, Mark D. P., et al.. (2008). Pruritic rash on the buttocks after a beach vacation: a case report.. PubMed. 82(2). 133–4. 1 indexed citations
11.
Maćkowiak, P., A.J. Eid, Mike Davis, et al.. (2007). A Young Man with Pyomyositis and Bullous Disease. Clinical Infectious Diseases. 45(6). 799–800. 1 indexed citations
12.
Kalaaji, Amer N.. (2007). Cytokine therapy in advanced melanoma.. PubMed. 6(4). 374–8. 6 indexed citations
13.
Kalaaji, Amer N., et al.. (2006). Cytokines in dermatology.. PubMed. 5(6). 520–4. 13 indexed citations
14.
Kalaaji, Amer N., et al.. (2006). Mayo Clinic Atlas of Immunofluorescence in Dermatology. 4 indexed citations
15.
Kureshi, Faraz, et al.. (2006). Cutaneous complications of intravesical treatments for bladder cancer: Granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy. Journal of the American Academy of Dermatology. 55(2). 328–331. 23 indexed citations
16.
Kalaaji, Amer N., et al.. (2005). Pancreatic Panniculitis Due to Pancreatic Carcinoma. Mayo Clinic Proceedings. 80(6). 822–822. 3 indexed citations
17.
Kalaaji, Amer N., et al.. (2004). Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma. Journal of the American Academy of Dermatology. 51(1). 103–110. 41 indexed citations
18.
Kalaaji, Amer N., et al.. (2004). Recurrent Palmoplantar Hidradenitis with Exclusive Palmar Involvement and an Association with Trauma and Exposure to Aluminum Dust. Pediatric Dermatology. 21(1). 30–32. 3 indexed citations
19.
Kalaaji, Amer N., Margaret Douglass, Marsha Chaffins, & Lori Lowe. (1998). Calciphylaxis: A Cause of Necrotic Ulcers in Renal Failure. Journal of Cutaneous Medicine and Surgery. 2(4). 242–244. 11 indexed citations
20.
Kalaaji, Amer N., Ken McCullough, & John B. Hay. (1989). The enhancement of lymphocyte localization in skin sites of sheep by tumor necrosis factor alpha. Immunology Letters. 23(2). 143–147. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neetu Bhari Breakdown of academic impact, for papers by Bela Shah Breakdown of academic impact, for papers by Parvaneh Hatami Breakdown of academic impact, for papers by O Mourellou Breakdown of academic impact, for papers by Ibrahim Galadari Breakdown of academic impact, for papers by Vincent P. Barranco Breakdown of academic impact, for papers by Ayşe Esra Koku Aksu Breakdown of academic impact, for papers by Sascha Ständer Breakdown of academic impact, for papers by Yukie Endo Breakdown of academic impact, for papers by Maria Manuel Brites
Rankless by CCL
2026